COVID-19 - where do we go from here?
The cluster of viral pneumonia cases that first began in Wuhan, Hubei province, China, in December 2019 has rapidly spread within China and globally. The virus responsible was subsequently identified on 7 January 2020 and the infection was given the official name of coronavirus disease 2019 (COVID-1...
Main Authors: | Lee, Pei Hua, Vasoo, Shawn |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/145198 |
Similar Items
-
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
by: Poh, Xuan Ying, et al.
Published: (2023) -
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023) -
Artificial Intelligence and Machine Learning for COVID-19 /
by: Al-Turjman, Fadi, editor 622956
Published: ([202) -
Antibiotic therapy in the treatment of COVID-19 pneumonia: who and when?
by: Ng, Tat Ming, et al.
Published: (2023) -
Environmental contamination in a coronavirus disease 2019 (COVID-19) intensive care unit—what is the risk?
by: Ong, Sean Wei Xiang, et al.
Published: (2022)